• cfhix
• Mutual Fund
• Commodities
• Broad

Catalyst Hedged Commodity Strategy Fund Class I

Expenses: 2.01% (Better than 0% of similar funds)

This is a bad choice for a Broad Commodities fund. See why »

• dadgx
• Mutual Fund
• US Stocks
• Small Growth

Dunham Small Cap Growth Fund Class A

Expenses: 2.13% (Better than 0% of similar funds)

This is a bad choice for a Small Growth US Stocks fund. See why »

• repix
• Mutual Fund
• Alternative
• Leveraged Equities

ProFunds Real Estate UltraSector Fund Investor Class

Expenses: 1.62% (Better than 0% of similar funds)

This is a bad choice for a Leveraged Equities Alternative fund. See why »

• cnjfx
• Mutual Fund
• International Stocks
• Japan Stock

Commonwealth Japan Fund

Expenses: 1.75% (Better than 0% of similar funds)

This is a bad choice for a Japan Stock International Stocks fund. See why »

• mveix
• Mutual Fund
• US Stocks
• Mid-Cap Value

Monteagle Select Value Fund Class I

Expenses: 1.36% (Better than 0% of similar funds)

This is a bad choice for a Mid-Cap Value US Stocks fund. See why »

• cyb
• ETF
• Money Market
• Single Currency

WisdomTree Chinese Yuan Strategy Fund

Expenses: 0.45% (Better than 0% of similar funds)

This is a bad choice for a Single Currency Money Market fund. See why »

• mwsix
• Mutual Fund
• Bond
• High Yield Bond

Metropolitan West Strategic Income Fund Class Institutional

Expenses: 1.53% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• pdecx
• Mutual Fund
• International Stocks
• Emerging Markets

PGIM Jennison Emerging Markets Equity Opportunities Fund- Class C

Expenses: 2.20% (Better than 0% of similar funds)

This is a bad choice for a Emerging Markets International Stocks fund. See why »

• ryfix
• Mutual Fund
• Sector Equity
• Financial Services

Rydex Financial Services Fund Class Investor

Expenses: 1.45% (Better than 0% of similar funds)

This is a bad choice for a Financial Services Sector Equity fund. See why »

• rycfx
• Mutual Fund
• Sector Equity
• Healthcare

Rydex Biotechnology Fund Class C

Expenses: 2.46% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »